Velsera Appoints Jamie Coffin, PhD, as Chief Executive Officer
Read more
News
On January 22, 2026 | By Johanna Samuelsson
News
On June 24, 2025 | By Brian Lassiter
Velsera’s Global Data Network Redefines How Pharma and Biotech Access Real-World, Longitudinal Clinicogenomic Data at Scale
Read more
News
On May 30, 2025 | By Brian Lassiter
Velsera Powers the Knowledgebase Behind Illumina’s TSO Comprehensive Test, Now Approved in Japan
Read more
News
On February 20, 2025 | By Brian Lassiter
Velsera Drives Momentum in 2024 with Key Platform Advancements and Strategic Growth
Read more
News
On October 8, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Diagnostica Longwood Partner to Revolutionize Access to Precision Genomics for Patients in Spain and Portugal
Read more
News
On September 16, 2024 | By The Velsera Clinical and Compliance Team
Velsera Technology Paves the Way for Advanced Cancer Diagnostics with FDA Approval of Illumina TruSight™ Oncology Comprehensive IVD
Read more
News
On June 28, 2024 | By The Velsera Clinical and Compliance Team
Genoks and Velsera Forge Strategic Partnership to Revolutionize Cancer Diagnostics in Turkey
Read more
News
On June 27, 2024 | By The Velsera Clinical and Compliance Team
Genetic Sequence Data Analysis & Reporting Accelerated with Velsera’s Release of CGW Plus
Read more
News
On June 3, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Sentieon’s Pangenotyper Wins Bio-IT World 2024 Best-of-Show
Read more
News
On April 4, 2024 | By The Velsera Clinical and Compliance Team
Velsera and Flywheel Team up to Support Multimodal Imaging Genomics Research
Read more
News
On March 5, 2024 | By The Velsera Clinical and Compliance Team
Velsera Announces Appointment of Jamie Littlejohns as New Chief Executive Officer
Read more
News
On November 15, 2023 | By The Velsera Clinical and Compliance Team
Faster, smarter clinical interpretation workflows unveiled on CGW platform
Read more